Current and future applications of target-controlled infusions

Drugs of Today

Volumn 35, Issue 11, 1999, Pages 823-834

  Absalom, A ^a   Kenny, G N C ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALFENTANIL; MIDAZOLAM; PROPOFOL; REMIFENTANIL; SUFENTANIL;

ANALGESIA; CALCULATION; COMPUTER; COMPUTER SYSTEM; DRUG DELIVERY SYSTEM; GENERAL ANESTHESIA; MICROPROCESSOR; REVIEW; SEDATION;

EID: 0033382902     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: None     Document Type: Review

References (71)

1. Schüttler, J., Kloos, S., Schwilden, H., Stoeckel, H. Total intravenous anaesthesia with propofol and alfentanil by computer-assisted infusion. Anaesthesia 1988, 43(Suppl.): 2-7.
2. White, M., Kenny, G.N. Intravenous propofol anaesthesia using a computerised infusion system. Anaesthesia 1990, 45: 204-9.
3. Glass, P.S., Goodman, D.K., Ginsberg, B., Reves, J.G., Jacobs, J.R. Accuracy of pharmacokinetic model-driven infusion of propofol. Anesthesiology 1989, 71: A277.
4. Jain, U., Wahr, J., Communale, M., Bellows, W., Mathew, J., and the McSPI Research Group. Myocardial ischemia and infarction during CABG with a pharmacokinetics based propofol infusion. Anesthesiology 1994, 81: A549.
5. Tackley, R.M., Lewis, G.T., Prys-Roberts, C., Boaden, R.W., Dixon, J., Harvey, J.T. Computer controlled infusion of propofol. Br J Anaesth 1989, 62: 46-53.
6. Mulder, S.M., Engbers, F.H., Jannsen, C.T. Target-controlled infusion with propofol: A clinical evaluation. Br J Anaesth 1995; 74: A274.
7. Suttner, S., Boldt, J., Schmidt, C., Piper, S., Kumle, B. Cost analysis of target-controlled infusion-based anesthesia compared with standard anesthesia regimens. Anesth Analg 1999, 88: 77-82.
8. Rowe, L. Economics and anaesthesia. Anaesthesia 1998, 53: 782-8.
9. Orkin, F.K. What do patients want? Preferences for immediate recovery. Anesth Analg 1992, 74: 225.
10. Taylor, I.N., White, M., Kenny, G.N. Assessment of the value and pattern of use of a target controlled propofol infusion system. Int J Clin Mon Comp 1993, 10: 175-80.
11. Russell, D., Wilkes, M.P., Hunter, S.C., Glen, J.B., Hutton, P.K., Kenny, G.N. Manual compared with target-controlled infusion of propofol. Br J Anaesth 1995, 75: 562-6.
12. Glen, J.B. Quality of anaesthesia during spontaneous respiration: A proposed scoring system. Anaesthesia 1991, 46: 1081-2.
13. Swinhoe, C.F., Peacock, J.E., Reilly, C.S. Evaluation of the accuracy of the "Diprifusor". Eur J Anaesth 1995, 10(Suppl.): 84.
14. Struys, M., Versichelen, L., Rolly, G. Influence of pre-anaesthetic medication on target propofol concentration using a "Diprifusor" TCI system during ambulatory surgery. Anaesthesia 1998, 53(Suppl. 1): 68-71.
15. Servin, F.S., Marchand-Maillet, F., Desmonts, J.M. Influence of analgesic supplementation on the target propofol concentrations for anaesthesia with "Diprifusor" TCI. Anaesthesia 1998, 53(Suppl. 1): 72-6.
16. Richards, A.L., Orton, J.K., Gregory, M.J. Influence of ventilatory mode on target concentrations required for anaesthesia using a "Diprifusor" TCI system. Anaesthesia 1998, 53(Suppl. 1): 77-81.
17. Barvais, L., Rausin, I., Glen, J.B. et al. Administration of propofol by target-controlled infusion in patients undergoing coronary artery surgery. J Cardiothorac Vasc Anesth 1996, 10: 877-83.
18. Servin, F.S. TCI compared with manually controlled infusion of propofol: A multicentre study. Anaesthesia 1998, 53(Suppl. 1):82-6.
19. Glass, P.J.A., Jacobs, J.R., Reves, J.G. Intravenous drug delivery. In: Anesthesia. Miller, R.D. (Ed). Churchill Livingstone: New York 1990, 367.
20. Swinhoe, C.F., Peacock, J.E., Glen, J.B., Reilly, C.S. Evaluation of the predictive performance of a "Diprifusor" TCI system. Anaesthesia 1998, 53(Suppl. 1): 61-7.
21. 50 for propofol with and without 67% nitrous oxide. Acta Anaesthesiol Scand 1993, 37: 458-64.
22. Frei, F.J., Zbinden, A.M., Thomson, D.A., Rieder, H.U. Is the end-tidal partial pressure of isoflurane a good predictor of its arterial partial pressure? Br J Anaesth 1991, 66: 331-9.
23. Dwyer, R.C., Fee, J.P., Howard, P.J., Clarke, R.S. Arterial washin of halothane and isoflurane in young and elderly adult patients. Br J Anaesth 1991, 66: 572-9.
24. Watt, I., Ledingham, I.M. Mortality amongst multiple trauma patients admitted to an intensive therapy unit. Anaesthesia 1984, 39: 973-81.
25. Wagner, R.L., White, P.F. Etomidate inhibits adrenocortical function in surgical patients. Anesthesiology 1984, 61: 647-51.
26. Bowdle, T.A., Radant, A.D., Cowley, D.S., Kharasch, E.D., Strassman, R.J., Roy, B.P.P. Psychedelic effects of ketamine in healthy volunteers: Relationship to steady-state plasma concentrations. Anesthesiology 1998, 88: 82-8.
27. Church, J.A., Stanton, P.D., Kenny, G.N., Anderson, J.R. Propofol for sedation during endoscopy: Assessment of a computer-controlled infusion system. Gastrointest Endosc 1991, 37: 175-9.
28. Skipsey, I.G., Colvin, J.R., Mackenzie, N., Kenny, G.N. Sedation with propofol during surgery under local blockade. Assessment of a target-controlled infusion system. Anaesthesia 1993, 48: 210-3.
29. Murdoch, J.A., Kenny, G.N. Patient-maintained propofol sedation as a premedication in day case surgery: Assessment of a target-controlled system. Br J Anaesth 1999, 82: 429-31.
30. Dell, R. A review of patient-controlled sedation. Eur J Anaesth 1996, 13: 547-52.
31. Irwin, M.G., Thompson, N., Kenny, G.N. Patient maintained propofol sedation. Assessment of a target-controlled infusion system. Anaesthesia 1997, 52: 525-30.
32. Somma, J., Donner, A., Zomorodi, K. et al. Population pharmacodynamics of midazolam administered by target controlled infusion in SICU patients after CABG surgery. Anesthesiology 1998, 89: 1430-43.
33. Vuyk, J., Lim, T., Engbers, F.H., Burm, A.G., Vletter, A.A., Bovill, J.G. Pharmacodynamics of alfentanil as a supplement to propofol or nitrous oxide for lower abdominal surgery in female patients. Anesthesiology 1993, 78: 1036-45.
34. Vuyk, J., Lim, T., Engbers, F.H., Burm, A.G., Vletter, A.A., Bovill, J.G. The pharmacodynamic interaction of propofol and alfentanil during lower abdominal surgery in women. Anesthesiology 1995, 83: 8-22.
35. Crankshaw, D.P., Morgan, D.J., Beemer, G.H., Karasawa, F. Preprogrammed infusion of alfentanil to constant arterial plasma concentration. Anesth Analg 1993, 76: 556-61.
36. Westmoreland, C.L., Sebel, P.S., Gropper, A. Fentanyl or alfentanil decreases the minimum alveolar anesthetic concentration of isoflurane in surgical patients. Anesth Analg 1994, 78: 23-8.
37. Davies, F.W., White, M., Kenny, G.N. Postoperative analgesia using a computerised infusion of alfentanil following aortic bifurcation graft surgery. Int J Clin Mon Comp 1992, 9: 207-12.
38. van den Nieuwenhuyzen, M.C., Engbers, F.H., Burm, A.G. et al. Computer-controlled infusion of alfentanil for postoperative analgesia. A pharmacokinetic and pharmacodynamic evaluation. Anesthesiology 1993, 79: 481-92.
39. Irwin, M.G., Jones, R.D., Visram, A.R., Kornberg, J.P. A patient's experience of a new post-operative patient-controlled analgesic technique. Eur J Anaesth 1994, 11: 413-5.
40. Checketts, M.R., Gilhooly, C.J., Kenny, G.N. Patient-maintained analgesia with target controlled alfentanil after cardiac surgery: A comparison with morphine PCA. Br J Anaesth 1998, 80: 748-51.
41. Irwin, M.G., Jones, R.D., Visram, A.R., Kenny, G.N. Patient-controlled alfentanil. Target-controlled infusion for postoperative analgesia. Anaesthesia 1996, 51: 427-30.
42. Irwin, M.G., Campbell, R.C., Lun, T.S., Yang, J.C. Patient maintained alfentanil target-controlled infusion for analgesia during extracorporeal shock wave lithotripsy. Can J Anaesth 1996, 43: 919-24.
43. Egan, T.D., Minto, C.F., Hermann, D.J., Barr, J., Muir, K.T., Shafer, S.L. Remifentanil versus alfentanil: Comparative pharmacokinetics and pharmacodynamics in healthy adult male volunteers. Anesthesiology 1996, 84: 821-33.
44. Kapila, A., Glass, P.S., Jacobs, J.R. et al. Measured context-sensitive half-times of remifentanil and alfentanil. Anesthesiology 1995, 83: 968-75.
45. Dershwitz, M., Hoke, J.F., Rosow, C.E. et al. Pharmacokinetics and pharmacodynamics of remifentanil in volunteer subjects with severe liver disease. Anesthesiology 1996, 84: 812-20.
46. Lang, E., Kapila, A., Shlugman, D., Hoke, J.F., Sebel, P.S., Glass, P.S. Reduction of isoflurane minimal alveolar concentration by remifentanil. Anesthesiology 1996, 85: 721-8.
47. Milne, S.E., Kenny, G.N.C. Increasing the remifentanil target blood concentration reduces closed-loop propofol administration. Anaesthesia 1999, 82: A395.
48. Dershwitz, M., Randel, G.I., Rosow, C.E. et al. Initial clinical experience with remifentanil, a new opioid metabolized by esterases. Anesth Analg 1995, 81: 619-23.
49. Bowdle, T.A., Camporesi, E.M., Maysick, L. A multicenter evaluation of remifentanil for early postoperative analgesia. Anesth Analg 1996, 83: 1292-7.
50. Schüttler, J., Albrecht, S., Breivik, H. et al. A comparison of remifentanil and alfentanil in patients undergoing major abdominal surgery. Anaesthesia 1997, 52: 307-17.
51. Yarmush, J.M., D'Angelo, R.D., Kirkhart, B.S. et al. A comparison of remifentanil and morphine sulphate for acute postoperative analgesia after total intravenous anesthesia with remifentanil and propofol. Anesthesiology 1997, 87: 235-43.
52. Schraag, S., Kenny, G.N., Mohl, U., Georgieff, M. Patient-maintained target-controlled remifentanil for the transition to early postoperative analgesia. Br J Anaesth 1998, 81: 365-8.
53. Shafer, S.L., Varvel, J.R. Pharmacokinetics, pharmacodynamics, and rational opioid selection. Anesthesiology 1991, 74: 53-63.
54. Gepts, E., Shafer, S.L., Camu, F. et al. Linearity of pharmacokinetics and model estimation of sufentanil. Anesthesiology 1995, 83: 1194-204.
55. Hughes, M.A., Glass, P.S., Jacobs, J.R. Context-sensitive half-time in multicompartment pharmacokinetic models for intravenous anesthetic drugs. Anesthesiology 1992, 76: 334-41.
56. Hans, P., Lamy, M.M., Brichant, J.F. et al. Emergence from target-controlled anesthesia with propofol and sufentanil in patients undergoing intracranial surgery. Acta Anaesth Belg 1998, 49: 13-9.
57. Schraag, S., Mohl, U., Hirsch, M., Stolberg, E., Georgieff, M. Recovery from opioid anesthesia: The clinical implication of context-sensitive half-times. Anesth Analg 1998, 86: 184-90.
58. Bailey, J.M., Schwieger, I.M., Hug, C.C. Jr. Evaluation of sufentanil anesthesia obtained by a computer-controlled infusion for cardiac surgery. Anesth Analg 1993, 76: 247-52.
59. McEwan, A.I., Smith, C., Dyar, O., Goodman, D., Smith, L.R., Glass, P.S. Isoflurane minimum alveolar concentration reduction by fentanyl. Anesthesiology 1993, 78: 864-9.
60. Katoh, T., Uchiyama, T., Ikeda, K. Effect of fentanyl on awakening concentration of sevoflurane. Br J Anaesth 1994, 73: 322-5.
61. Smith, C., McEwan, A.I., Jhaveri, R. et al. The interaction of fentanyl on the Cp50 of propofol for loss of consciousness and skin incision. Anesthesiology 1994, 81: 820-8.
62. Ginsberg, B., Howell, S., Glass, P.S. et al. Pharmacokinetic model-driven infusion of fentanyl in children. Anesthesiology 1996, 85: 1268-75.
63. Bailey, J.M. Pharmacodynamics as a research tool. J Clin Anesth 1996, 8(3, Suppl.): 48-52S.
64. Alfonsi, P., Sessler, D.I., Du Manoir, B., Levron, J.C., Le Moing, J.P., Chauvin, M. The effects of meperidine and sufentanil on the shivering threshold in postoperative patients. Anesthesiology 1998, 89: 43-8.
65. Schwilden, H., Schüttler, J., Stoeckel, H. Closed-loop feedback control of methohexital anesthesia by quantitative EEG analysis in humans. Anesthesiology 1987, 67: 341-7.
66. Schwilden, H., Stoeckel, H., Schüttler, J. Closed-loop feedback control of propofol anaesthesia by quantitative EEG analysis in humans. Br J Anaesth 1989, 62: 290-6.
67. Schwilden, H., Stoeckel, H. Closed-loop feedback controlled administration of alfentanil during alfentanil-nitrous oxide anaesthesia. Br J Anaesth 1993, 70: 389-93.
68. Kenny, G.N., Mantzaridis, H. Closed-loop control of propofol anaesthesia. Br J Anaesth 1999, 83: 223-8.
69. Mortier, E., Struys, M., De Smet, T., Versichelen, L., Rolly, G. Closed-loop controlled administration of propofol using bispectral analysis. Anaesthesia 1998, 53: 749-54.
70. Jacobs, J.R., Reves, J.G. Effect site equilibration time is a determinant of induction dose requirement. Anesth Analg 1993, 76: 1-6.
71. White, M., Schenkels, M.J., Engbers, F.H. et al. Effect-site modelling of propofol using auditory evoked potentials. Br J Anaesth 1999, 82: 333-9.